Carson Wealth (CWM LLC)’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$94.1K Buy
6,314
+30
+0.5% +$668 ﹤0.01% 3329
2025
Q4
$157K Sell
6,284
-29
-0.5% -$516 ﹤0.01% 2752
2025
Q3
$62K Buy
6,313
+111
+2% +$666 ﹤0.01% 3351
2025
Q2
$26K Buy
6,202
+2,022
+48% +$9.02K ﹤0.01% 3746
2025
Q1
$16K Buy
4,180
+4,132
+8,608% +$20.8K ﹤0.01% 3837
2024
Q4
$0 Sell
48
-1,047
-96% -$10.5K ﹤0.01% 5084
2024
Q3
$13K Buy
1,095
+12
+1% +$153 ﹤0.01% 3636
2024
Q2
$12K Buy
1,083
+63
+6% +$683 ﹤0.01% 3442
2024
Q1
$12K Hold
1,020
﹤0.01% 3239
2023
Q4
$14K Hold
1,020
﹤0.01% 2997
2023
Q3
$13K Hold
1,020
﹤0.01% 2992
2023
Q2
$9K Hold
1,020
﹤0.01% 3148
2023
Q1
$4K Hold
1,020
﹤0.01% 3408
2022
Q4
$2K Hold
1,020
﹤0.01% 3604
2022
Q3
$3K Hold
1,020
﹤0.01% 3340
2022
Q2
$4K Sell
1,020
-116
-10% -$368 ﹤0.01% 3113
2022
Q1
$5K Buy
1,136
+936
+468% +$5.16K ﹤0.01% 2854
2021
Q4
$2K Buy
+200
New +$4.14K ﹤0.01% 3155

Other funds holding OLMA

Carson Wealth (CWM LLC)'s OLMA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Olema Pharmaceuticals (OLMA) stake by 0.48% in Q1 2026, buying an estimated $668 and bringing the position to 6,314 shares worth $94.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3329.

Carson Wealth (CWM LLC) first reported a position in OLMA in Q4 2021 and has held it in 18 quarters since. The position peaked at $157K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 6,314 shares of Olema Pharmaceuticals worth $94.1K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 30 Olema Pharmaceuticals shares in Q1 2026, an estimated $668.
  • Olema Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3329 holding.
  • Carson Wealth (CWM LLC) first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s Olema Pharmaceuticals position peaked at $157K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.